Research map: Circulating leukocyte–platelet complexes as a predictive biomarker for the development of immune-related adverse events in advanced non-small cell lung cancer patients receiving anti-PD-(L)1 blocking agents

Back to the article

Papers in this map

  1. Nivolumab versus Docetaxel in Advanced Squamous-Cell Non–Small-Cell Lung Cancer · Julie Renee Brahmer · 2015 · 8636 citations · Cited by this paper
  2. Effects of the interactions between platelets with other cells in tumor growth and progression · Yaxin Li · 2023 · 62 citations · Cites this paper
  3. HBO1 suppresses anti-tumor immunity of CD8⁺ T Cells in thyroid cancer by recruiting BRD4 to regulate VTCN1 expression · 2026 · Related
  4. Oncology Meets Immunology: The Cancer-Immunity Cycle · Daniel S. Chen · 2013 · 7139 citations · Cited by this paper
  5. Monocyte-related markers as predictors of immune checkpoint inhibitor efficacy and immune-related adverse events: a systematic review and meta-analysis · Aiarpi A. Ezdoglian · 2025 · 25 citations · Cites this paper
  6. Conserved minimal CD8 cytotoxic immune-state unit in an IL18R1-associated immune program in hepatocellular carcinoma · 2026 · Related
  7. Immune-Related Adverse Events Associated with Immune Checkpoint Blockade · Michael Andrew Postow · 2018 · 4907 citations · Cited by this paper
  8. Phenotypic and Functional Consequences of PLT Binding to Monocytes and Its Association with Clinical Features in SLE · Anaís Mariscal · 2021 · 13 citations · Cites this paper
  9. Impact of neck nodal yield on immune checkpoint inhibitor outcome after recurrence in head and neck squamous cell carcinoma · 2026 · Related
  10. Pembrolizumab plus Chemotherapy for Squamous Non–Small-Cell Lung Cancer · Luis G Paz-Ares · 2018 · 3711 citations · Cited by this paper
  11. The role of circulating biomarkers in predicting the 30-day mortality of immune checkpoint inhibitors-related myocarditis: a retrospective cohort study · Yuansong Zhuang · 2024 · 12 citations · Cites this paper
  12. Preclinical efficacy of iPSC-derived MUC1-targeted CAR-NK cells against esophageal squamous cell carcinoma · 2026 · Related
  13. Direct Signaling between Platelets and Cancer Cells Induces an Epithelial-Mesenchymal-Like Transition and Promotes Metastasis · Myriam Labelle · 2011 · 1879 citations · Cited by this paper
  14. Factors associated with immune‑related severe adverse events (Review) · Zhenzhen Su · 2024 · 8 citations · Cites this paper
  15. Survival outcomes of conversion curative therapy following atezolizumab–bevacizumab in advanced hepatocellular carcinoma · 2026 · Related
  16. Atezolizumab in combination with carboplatin plus nab-paclitaxel chemotherapy compared with chemotherapy alone as first-line treatment for metastatic non-squamous non-small-cell lung cancer (IMpower130): a multicentre, randomised, open-label, phase 3 trial · Howard West · 2019 · 1712 citations · Cited by this paper
  17. Development and validation of a risk-prediction model for immune-related adverse events in patients with non-small-cell lung cancer receiving PD-1/PD-L1 inhibitors · Qing Qiu · 2023 · 5 citations · Cites this paper
  18. Integrative single-cell and multi-omics analysis of ZBTB21-mediated serine metabolism in colorectal cancer: from metabolic reprogramming to immune microenvironment modulation · 2026 · Related
  19. Circulating Cytokines Predict Immune-Related Toxicity in Melanoma Patients Receiving Anti-PD-1–Based Immunotherapy · Su Yin Lim · 2018 · 382 citations · Cited by this paper
  20. Potential Role of Circulating PD-L1+ Leukocytes as a Predictor of Response to Anti-PD-(L)1 Therapy in NSCLC Patients · Geòrgia Anguera · 2024 · 5 citations · Cites this paper
  21. Squeezing Treatment-Induced Metabolic Alterations in Melanoma Cells Are Accompanied by Impaired Cluster of Differentiation 8-Positive T Cell and Natural Killer Cell Antitumor Effector Functions · 2026 · Related
  22. Profiling Preexisting Antibodies in Patients Treated With Anti–PD-1 Therapy for Advanced Non–Small Cell Lung Cancer · Yukihiro Toi · 2018 · 374 citations · Cited by this paper
  23. Predictive Role of Prior Radiotherapy and Immunotherapy-Related Adverse Effects in Advanced NSCLC Patients Receiving Anti-PD-1/L1 Therapy · Jeong Uk Lim · 2021 · 3 citations · Cites this paper
  24. Platelets subvert T cell immunity against cancer via GARP-TGFβ axis · Saleh Rachidi · 2017 · 335 citations · Cited by this paper
  25. Monocyte-Related Markers as Predictors of Immune Checkpoint Inhibitor Efficacy and Immune-Related Adverse Events: A Systematic Review and Meta-Analysis · Aiarpi A. Ezdoglian · 2024 · 1 citation · Cites this paper
  26. Platelets in cancer metastasis: To help the “villain” to do evil · Nailin Li · 2015 · 232 citations · Cited by this paper
  27. 1,8-Cineole inhibits platelet-leukocyte aggregate formation by reducing P-selectin expression · Julie Petry · 2025 · 1 citation · Cites this paper
  28. Untitled · Cited by this paper
  29. Dermatotoxicity of Immune Checkpoint Inhibitors in Advanced Non-Small Cell Lung Cancer: Current Advances in Mechanistic Insights and Predictive Biomarker Identification · Shiliang Shao · 2025 · 1 citation · Cites this paper
  30. Untitled · Cited by this paper
  31. Risk factors for cutaneous immune-related adverse events: a systematic scoping review · Zhenzhen Su · 2026 · 1 citation · Cites this paper
  32. Untitled · Cited by this paper
  33. From escort to target, the multidimensional roles and prospects of platelets in tumor immune checkpoint inhibitor therapy · J G Xiao · 2026 · 1 citation · Cites this paper
  34. Untitled · Cited by this paper
  35. Association between the Immunophenotype of Peripheral Blood from mCRPC Patients and the Outcomes of Radium-223 Treatment · Elisabet Cantó · 2023 · Cites this paper
  36. Untitled · Cited by this paper
  37. The Potential Role of Circulating Inflammatory Cells in Predicting the Safety, Efficacy and Immune-related Adverse Events of Immune Check-point Inhibitors: A Narrative Review · Tibera K. Rugambwa · 2023 · Cites this paper
  38. Untitled · Cited by this paper
  39. Die Rolle von Plättchen-Leukozyten-Komplexen bei entzündlichen Erkrankungen des Gefäßsystems · Lisa-Marie Irschfeld · 2025 · Cites this paper

Source: OpenAlex (CC0)